For: |
Yin Y, Zhong L, Wang JW, Zhao XY, Zhao WJ, Kuang HX. Tong Xie Yao Fang relieves irritable bowel syndrome in rats |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i15/4536.htm |
Number | Citing Articles |
1 |
Min Chen, Di Qin, Shi‐Le Huang, Tai‐Chun Tang, Hui Zheng. Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta‐analysis. Neurogastroenterology & Motility 2021; 33(8) doi: 10.1111/nmo.14107
|
2 |
Qiuke Hou, Yongquan Huang, Zhaoyang Zhu, Liu Liao, Xinlin Chen, Quanbin Han, Fengbin Liu. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways. BMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2749-4
|
3 |
Thomas Theis, Suneel Kumar, Elena Wei, Jennifer Nguyen, Vicci Glynos, Nikita Paranjape, Hadi Askarifirouzjaei, Leila Khajouienejad, Francois Berthiaume, Wise Young, Melitta Schachner. Myristoylated alanine‐rich C‐kinase substrate effector domain peptide improves sex‐specific recovery and axonal regrowth after spinal cord injury. The FASEB Journal 2020; 34(9): 12677 doi: 10.1096/fj.202000026RR
|
4 |
Yan Wang, Yong-quan Huang, Shui-lian Zhu, Chang-rong Zhang, Xin-lin Chen, Qiu-ke Hou, Feng-bin Liu. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial. Trials 2020; 21(1) doi: 10.1186/s13063-020-04833-x
|
5 |
Yijie Li, Xiaolan Su, Peng Wu, Jifeng Wang, Yu Guo, Jiajie Zhu, Qingguo Wang, Jiande Chen, Fuquan Yang, Wei Wei. Proteomics analysis of IBS-D with spleen and kidney yang deficiency. Journal of Traditional Chinese Medical Sciences 2017; 4(1): 39 doi: 10.1016/j.jtcms.2017.05.006
|
6 |
Yaoliang Lai, Xiao Liang, Heng Fan, Yujin Liu, Liang Zheng, Weimin Lu, Yuling Sun, Dawei Huang, Xingxing Liu, Lijian Zhang, Dongmei Zuo, Zhexing Shou, Qing Tang, Yuanyuan Wang, Zhen Li, Zhengyan Jiang, Shuo Zang, Huisuo Huang, Zongxiang Tang, Qian Li, Jun Xiao. Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial. Complementary Therapies in Medicine 2022; 68: 102839 doi: 10.1016/j.ctim.2022.102839
|
7 |
Jutta Stolley. Chinesische Arzneitherapie bei Reizdarmsyndrom. Deutsche Zeitschrift für Akupunktur 2019; 62(1): 52 doi: 10.1007/s42212-019-0133-4
|
8 |
Xue-Ying Zhao, Jian-Wei Wang, Yue Yin, Kai Li, Miao Zhang, Fu-Ping Yan. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats. World Journal of Gastroenterology 2019; 25(34): 5134-5151 doi: 10.3748/wjg.v25.i34.5134
|
9 |
Yun-Yun Shao, Yi-Ting Guo, Jian-ping Gao, Jun-Jin Liu, Zhuang-Peng Chang, Xiao-Juan Feng, Ding Xu, Gui-Feng Deng, Rui-Gang Hou, XiuMin Li. Shaoyao‐Gancao Decoction Relieves Visceral Hyperalgesia in TNBS‐Induced Postinflammatory Irritable Bowel Syndrome via Inactivating Transient Receptor Potential Vanilloid Type 1 and Reducing Serotonin Synthesis. Evidence-Based Complementary and Alternative Medicine 2020; 2020(1) doi: 10.1155/2020/7830280
|
10 |
Gajin Han, Seok-Jae Ko, Keumji Kim, Hyejin Jun, Jae-Woo Park. The efficacy of the traditional Korean herbal medicine Tongsayobang for the treatment of irritable bowel syndrome. Medicine 2021; 100(48): e28116 doi: 10.1097/MD.0000000000028116
|
11 |
M. Chen, T.‐C. Tang, Y. Wang, J. Shui, X.‐H. Xiao, X. Lan, P. Yu, C. Zhang, S.‐H. Wang, J. Yao, H. Zheng, D.‐Q. Huang. Randomised clinical trial: Tong‐Xie‐Yao‐Fang granules versus placebo for patients with diarrhoea‐predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 2018; 48(2): 160 doi: 10.1111/apt.14817
|
12 |
Li-Li Zhang, Wan-Shan Hao, Meng Xu, Chang Li, Yuan-Yuan Shi. Modified Tong Xie Yao Fang relieves solitary rectal ulcer syndrome: A case report. World Journal of Clinical Cases 2019; 7(15): 2058-2064 doi: 10.12998/wjcc.v7.i15.2058
|
13 |
Ying Peng, Siqi Wang, Mengyue Wang, Fang Wang, Jingyu Yang, Chunfu Wu, Xiaobo Li. Dual effects on constipation and diarrhea: protective potential of Radix Inulae lactones on irritable bowel syndrome. RSC Advances 2016; 6(97): 94486 doi: 10.1039/C6RA18533A
|
14 |
Jinke Huang, Ting Chen, Jiaqi Zhang, Xiangxue Ma, Fengyun Wang, Xudong Tang. Overlapping Symptoms of Functional Gastrointestinal Disorders: Current Challenges and the Role of Traditional Chinese Medicine. The American Journal of Chinese Medicine 2023; 51(04): 833 doi: 10.1142/S0192415X23500398
|
15 |
Yifang Jiang, Yane Hu, Yi Yang, Ran Yan, Lili Zheng, Xi Fu, Chong Xiao, Fengming You. Tong-Xie-Yao-Fang promotes dendritic cells maturation and retards tumor growth in colorectal cancer mice with chronic restraint stress. Journal of Ethnopharmacology 2024; 319: 117069 doi: 10.1016/j.jep.2023.117069
|
16 |
Tongfei Feng, Yanlin Zhou, Bin Lv, Lijun Cai. Tongxieyaofang Decotion Alleviates IBS by Modulating CHRM3 and Gut Barrier. Drug Design, Development and Therapy 2024; : 3191 doi: 10.2147/DDDT.S455497
|
17 |
Yi-Lin Li, Cheng-Jiao Yao, Rong Lei, Fengjiao Xie, Qin Xiong, Li-Hong Luo, Pei-Min Feng. Acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome. Medicine 2020; 99(48): e23457 doi: 10.1097/MD.0000000000023457
|
18 |
Jutta Stolley. Behandlung der Diarrhö mit chinesischer Arzneitherapie. Deutsche Zeitschrift für Akupunktur 2018; 61(4): 249 doi: 10.1007/s42212-018-0095-y
|
19 |
Sheyda Ranjbar, Seyed Afshin Seyednejad, Shekoufeh Nikfar, Roja Rahimi, Mohammad Abdollahi. How can we develop better antispasmodics for irritable bowel syndrome?. Expert Opinion on Drug Discovery 2019; 14(6): 549 doi: 10.1080/17460441.2019.1593369
|